Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Author: Auditor

SOP for Blinding and Masking

Posted on By

Standard Operating Procedure for Participant and Investigator Masking Purpose This SOP outlines the procedures for blinding and masking in clinical trials and clinical studies. The goal is to maintain objectivity and integrity in the study by preventing bias and ensuring that participants and study personnel are unaware of the assigned interventions. Scope This SOP applies…

Read More “SOP for Blinding and Masking” »

Clinical Studies

SOP for Randomization and Allocation Procedures

Posted on By

Standard Operating Procedure for Randomization and Participant Allocation Purpose This SOP outlines the procedures for randomization and allocation in clinical trials and clinical studies. The goal is to ensure that participants are allocated to study arms or treatment groups in a fair and unbiased manner, thereby minimizing bias and enhancing the reliability of study results….

Read More “SOP for Randomization and Allocation Procedures” »

Clinical Studies

SOP for Pharmacovigilance and Drug Safety

Posted on By

Standard Operating Procedure for Drug Safety Monitoring Purpose This SOP outlines the procedures for pharmacovigilance and drug safety monitoring in clinical trials and clinical studies. The goal is to ensure the safety of participants by identifying, assessing, and managing any adverse events or drug-related risks throughout the study. Scope This SOP applies to all personnel…

Read More “SOP for Pharmacovigilance and Drug Safety” »

Clinical Studies

SOP for Post-study Follow-up

Posted on By

Protocol for Participant Monitoring after BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for conducting post-study follow-up activities with participants who have completed Bioavailability (BA) and Bioequivalence (BE) studies, ensuring their ongoing well-being, providing necessary support, and facilitating long-term data collection. Scope This SOP applies to all study…

Read More “SOP for Post-study Follow-up” »

Bioequivalence Bioavailability Study

SOP for Study Termination Procedures

Posted on By

Protocol for Ending BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the termination of Bioavailability (BA) and Bioequivalence (BE) studies, ensuring proper closure of study activities, data collection, and documentation in accordance with regulatory requirements and study protocols. Scope This SOP applies to all study personnel involved…

Read More “SOP for Study Termination Procedures” »

Bioequivalence Bioavailability Study

SOP for Handling Unblinding Procedures

Posted on By

Protocol for Unmasking Treatment Allocation in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the handling of unblinding procedures in Bioavailability (BA) and Bioequivalence (BE) studies, ensuring appropriate disclosure of treatment allocation while maintaining study integrity and participant confidentiality. Scope This SOP applies to all study personnel…

Read More “SOP for Handling Unblinding Procedures” »

Bioequivalence Bioavailability Study

SOP for Environmental Health and Safety in Clinical and Lab Settings

Posted on By

Protocol for Ensuring Environmental Health and Safety in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for maintaining environmental health and safety standards in clinical and laboratory settings involved in Bioavailability (BA) and Bioequivalence (BE) studies, ensuring the well-being of study personnel and compliance with regulatory requirements. Scope…

Read More “SOP for Environmental Health and Safety in Clinical and Lab Settings” »

Bioequivalence Bioavailability Study

SOP for Stability Testing of Study Compounds

Posted on By

Protocol for Assessing Stability of Investigational Compounds in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the stability testing of study compounds in Bioavailability (BA) and Bioequivalence (BE) studies, ensuring the integrity, potency, and safety of investigational products throughout the study duration. Scope This SOP applies to…

Read More “SOP for Stability Testing of Study Compounds” »

Bioequivalence Bioavailability Study

SOP for Sample Re-analysis Procedures

Posted on By

Protocol for Reassessment of Analytical Results in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the reanalysis of samples in Bioavailability (BA) and Bioequivalence (BE) studies, ensuring accuracy, reliability, and integrity of analytical results. Scope This SOP applies to all study personnel involved in the reanalysis of…

Read More “SOP for Sample Re-analysis Procedures” »

Bioequivalence Bioavailability Study

SOP for Cross-validation of Bioanalytical Methods

Posted on By

Protocol for Verification of Bioanalytical Method Performance in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the cross-validation of bioanalytical methods used in Bioavailability (BA) and Bioequivalence (BE) studies, ensuring accuracy, reliability, and consistency of analytical results. Scope This SOP applies to all study personnel involved in…

Read More “SOP for Cross-validation of Bioanalytical Methods” »

Bioequivalence Bioavailability Study

Posts pagination

Previous 1 … 696 697 698 … 754 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Free GMP Video Content

Before You Leave...

Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.

  • Practical GMP scenarios
  • Inspection and compliance lessons
  • Short, useful, no-fluff videos
Visit GMP Scenarios on YouTube
Useful content only. No nonsense.